American Shared Hospital Service (AMS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • AMEX
Market Cap: $7.18M
Last updated: Nov 17, 2026 at 10:44 AM ET
American Shared Hospital Service (AMS) Financials: Revenue, Profit and Cash Flow
American Shared Hospital Service reported revenue of $28.08M for the fiscal year ended Dec 31, 2025, down 0.9% from the year before. That year, net income was -$2.73M with a net margin of -9.7%, operating cash flow was $3.10M and free cash flow was -$4.54M. The quarter ended Sep 30, 2026 had revenue of $7.62M and net income of -$906.00K.
Revenue and Margins
The operating margin was -7.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $18.70M, a compound annual rate of 4.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $28.08M | -0.9% | 18.0% | -7.2% | -9.7% |
| Dec 2024 | $28.34M | +32.9% | 32.4% | -4.6% | 5.4% |
| Dec 2023 | $21.32M | +8.0% | 43.8% | 6.5% | 1.2% |
| Dec 2022 | $19.75M | +12.0% | 42.4% | 16.4% | 7.9% |
| Dec 2021 | $17.63M | -1.2% | 38.2% | 11.9% | 3.8% |
| Dec 2020 | $17.84M | -13.4% | 25.0% | -47.1% | -43.3% |
| Dec 2019 | $20.61M | +4.5% | 33.6% | 13.9% | 6.9% |
| Dec 2018 | $19.71M | +0.8% | 38.0% | 17.7% | 8.3% |
| Dec 2017 | $19.56M | +4.6% | 44.3% | 22.2% | 15.0% |
| Dec 2016 | $18.70M | N/A | 47.0% | 26.7% | 12.0% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.08M | $28.34M | $21.32M | $19.75M | $17.63M | $17.84M | $20.61M | $19.71M | $19.56M | $18.70M |
| Cost of revenue | $23.02M | $19.16M | $11.98M | $11.36M | $10.90M | $13.37M | $13.69M | $12.23M | $10.89M | $9.90M |
| Gross profit | $5.06M | $9.19M | $9.34M | $8.38M | $6.73M | $4.47M | $6.92M | $7.49M | $8.66M | $8.79M |
| Operating income | -$2.01M | -$1.31M | $1.38M | $3.24M | $2.09M | -$8.41M | $2.86M | $3.49M | $4.34M | $4.99M |
| Net income | -$2.73M | $1.53M | $265.00K | $1.55M | $678.00K | -$7.72M | $1.43M | $1.63M | $2.94M | $2.25M |
| EBITDA | $3.83M | $8.76M | $6.59M | $8.10M | $7.12M | -$1.44M | $10.27M | $10.31M | $11.10M | $11.32M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.62M | $8.43M | $7.08M | $7.73M | $7.17M | $7.07M | $6.11M | $9.07M | $7.00M | $7.06M | $5.22M | $5.70M |
| Gross profit | $1.52M | $1.43M | $1.29M | $906.00K | $1.59M | $1.63M | $942.00K | $3.20M | $1.37M | $2.47M | $2.14M | $2.82M |
| Operating income | -$284.00K | -$609.00K | -$622.00K | -$1.08M | $48.00K | -$116.00K | -$866.00K | -$1.40M | -$553.00K | $384.00K | $264.00K | $694.00K |
| Net income | -$906.00K | -$998.00K | -$962.00K | -$1.01M | -$329.00K | -$478.00K | -$912.00K | -$1.89M | -$410.00K | $3.77M | $65.00K | $177.00K |
Balance Sheet
As of Dec 2025, total debt of $17.29M exceeded cash and equivalents by $13.83M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $55.48M | $60.20M | $48.16M | $43.96M | $45.43M | $43.65M | $53.78M | $57.50M | $58.18M | $60.60M |
| Current assets | $17.72M | $26.26M | $20.46M | $18.72M | $15.09M | $10.85M | $10.74M | $9.95M | $8.89M | $7.87M |
| Cash and equivalents | $3.46M | $11.03M | $13.69M | $12.34M | $8.14M | $3.96M | $1.43M | $1.44M | $2.15M | $2.87M |
| Total liabilities | $27.79M | $30.17M | $21.88M | $18.33M | $21.19M | $20.00M | $21.97M | $26.45M | $28.29M | $33.42M |
| Short-term debt | $17.29M | $2.84M | $4.58M | $1.26M | $1.08M | $1.16M | $1.53M | $6.53M | $7.27M | $7.08M |
| Long-term debt | $0 | $17.34M | $11.04M | $12.21M | $14.32M | $3.44M | $1.95M | $3.33M | $3.60M | $5.11M |
| Shareholder equity | $24.03M | $25.18M | $22.62M | $21.63M | $19.89M | $19.27M | $26.03M | $25.10M | $23.86M | $21.50M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $52.87M | $52.49M | $54.73M | $55.48M | $59.63M | $63.49M | $63.31M | $60.20M | $63.27M | $60.83M | $50.12M | $48.16M |
| Total liabilities | $27.84M | $26.68M | $28.02M | $27.79M | $31.03M | $34.65M | $34.10M | $35.01M | $31.44M | $28.47M | $23.74M | $10.78M |
| Cash and equivalents | $7.23M | $6.51M | $4.97M | $3.46M | $5.09M | $11.08M | $11.24M | $11.03M | $13.83M | $14.24M | $12.79M | $13.81M |
| Shareholder equity | $22.61M | $23.11M | $23.52M | $24.03M | $24.57M | $24.48M | $24.65M | $25.18M | $26.42M | $26.54M | $22.84M | $22.62M |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.10M | $167.00K | $5.72M | $7.24M | $6.27M | $9.74M | $8.05M | $8.06M | $7.85M | $8.38M |
| Capital expenditures | $7.63M | $7.94M | $6.27M | $388.00K | $1.67M | $455.00K | $990.00K | $1.58M | $803.00K | $1.04M |
| Free cash flow | -$4.54M | -$7.77M | -$555.00K | $6.85M | $4.59M | $9.29M | $7.06M | $6.49M | $7.05M | $7.34M |
| Dividends paid | $21.00K | $95.00K | $0 | $573.00K | $514.00K | $761.00K | $939.00K | $690.00K | $666.00K | $699.00K |
| Investing cash flow | -$7.63M | -$7.11M | -$6.27M | -$388.00K | -$1.67M | -$2.39M | -$990.00K | -$1.53M | -$653.00K | -$1.04M |
| Financing cash flow | -$3.03M | $4.41M | $1.91M | -$2.66M | -$655.00K | -$4.81M | -$7.07M | -$7.25M | -$7.82M | -$6.47M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.42M | $2.24M | $2.15M | -$704.00K | $1.67M | -$372.00K | $2.50M | $274.00K | $472.00K | $1.29M | -$1.86M | -$3.06M |
| Capital expenditures | $76.00K | $58.00K | $41.00K | $1.98M | $3.70M | $1.90M | $4.01M | $4.66M | $879.00K | $1.22M | $1.18M | $97.00K |
| Free cash flow | $1.35M | $2.18M | $2.11M | -$2.69M | -$2.03M | -$2.27M | -$1.51M | -$4.39M | -$407.00K | $70.00K | -$3.05M | -$3.16M |
Frequently Asked Questions About AMS
What is American Shared Hospital Service's annual revenue?
American Shared Hospital Service reported revenue of $28.08M for the fiscal year ended Dec 31, 2025.
How fast is American Shared Hospital Service's revenue growing?
Revenue was down 0.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.5%.
Is American Shared Hospital Service profitable?
No. American Shared Hospital Service reported net income of -$2.73M for the fiscal year ended Dec 31, 2025, with a net margin of -9.7%.
How much free cash flow does AMS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $3.10M minus capital expenditures of $7.63M produced free cash flow of -$4.54M.
How much debt does American Shared Hospital Service have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $17.29M and cash and equivalents of $3.46M.
AMS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors